BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dana-Farber Cancer Institute - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Dana-Farber Cancer Institute
X-ORIGINAL-URL:https://ds.dfci.harvard.edu
X-WR-CALDESC:Events for Dana-Farber Cancer Institute
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230214T130000
DTEND;TZID=America/New_York:20230214T140000
DTSTAMP:20260421T022914
CREATED:20221128T194757Z
LAST-MODIFIED:20230307T152329Z
UID:3899-1676379600-1676383200@ds.dfci.harvard.edu
SUMMARY:Using the Case Study of Atezolizumab Development to Rethink Early Phase Oncology Trial Design
DESCRIPTION:Frontiers in Biostatistics Seminar \nTuesday February 14\, 2023\n1:00PM Eastern Time\nYouTube video \nEmily Zabor\, DrPH\nAssistant Staff Biostatistician\nDepartment of Quantitative Health Sciences at the Cleveland Clinic\, with a joint appointment in the Taussig Cancer Institute\nAssistant Professor of Medicine\, the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
URL:https://ds.dfci.harvard.edu/event/frontiers-in-biostatistics-emily-zabor/
CATEGORIES:Seminar
ATTACH;FMTTYPE=image/jpeg:https://ds.dfci.harvard.edu/wp-content/uploads/2022/11/emily-touched-8-crop-scaled-e1669664843585.jpg
END:VEVENT
END:VCALENDAR